Fungal biotransformation of mosapride by Cunninghamella elegans

作者: Xiao-Hong Sun , Feng Man , Li-Yan Pang , Gui-Hua Gao , Xiao-Qin Li

DOI: 10.1016/J.MOLCATB.2009.01.009

关键词:

摘要: Abstract The filamentous fungus, Cunninghamella elegans AS 3.156, was used as a microbial model of mammalian metabolism to transform mosapride, selective 5-HT4-receptor agonist. fungal metabolites mosapride were separated and detected by ultra performance liquid chromatography–tandem mass spectrometric method. After incubation for 120 h, the parent drug metabolized thirteen metabolites, one which known major metabolite, des-p-fluorobenzyl while others all novel metabolites. Four including three new metabolite in mammals isolated using preparative high-performance chromatography identified 1D- 2D-nuclear magnetic resonance, UV spectroscopic analysis. Other characterized according their chromatographic behavior, spectral data. metabolic pathways transformed fungus N-oxidation, morpholinyl ring cleavage, N-dealkylation p-fluorobenzyl further N-formylation, minor N-dealkylation, glucoside conjugation, sulfate formylation opened followed acetylation. fungi belonging species could not only be generate microgram scale, but also facilitate production putative or derivatives. isolates reference standards identification analytical tests mosapride.

参考文章(25)
T Nomiyama, Y Sekine, H Miyazaki, M Sakashita, S Harasawa, S Tanaka, T Miwa, T Yamaguchi, Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Drug Research. ,vol. 43, pp. 867- 872 ,(1993)
Yoshida K, Sekine Y, Itogawa A, Tagawa M, Miyazaki H, Matsumoto S, Fujii T, Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Drug Research. ,vol. 43, pp. 1095- 1102 ,(1993)
Hatoyama T, Sekine Y, Tagawa M, Miyazaki H, Matsumoto S, Fujii T, Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats. Drug Research. ,vol. 43, pp. 1103- 1108 ,(1993)
E A Abourashed, A M Clark, C D Hufford, Microbial models of mammalian metabolism of xenobiotics: An updated review. Current Medicinal Chemistry. ,vol. 6, pp. 359- 374 ,(1999)
James P. Freeman, Carl E. Cerniglia, Joanna D. Moody, Biotransformation of doxepin by Cunninghamella elegans. Drug Metabolism and Disposition. ,vol. 27, pp. 1157- 1164 ,(1999)
Takashi Yoshikawa, Naoyuki Yoshida, Yukiko Mine, Kanoo Hosoki, Affinity of Mosapride Citrate, a New Gastroprokinetic Agent, for 5-HT4 Receptors in Guinea Pig Ileum Japanese Journal of Pharmacology. ,vol. 77, pp. 53- 60 ,(1998) , 10.1254/JJP.77.53
David A. Griffiths, David J. Best, Serge G. Jezequel, The screening of selected microorganisms for use as models of mammalian drug metabolism. Applied Microbiology and Biotechnology. ,vol. 35, pp. 373- 381 ,(1991) , 10.1007/BF00172729
Zhi Liu, Ryuji Sakakibara, Takeo Odaka, Tomoyuki Uchiyama, Tomoyuki Uchiyama, Tatsuya Yamamoto, Takashi Ito, Masato Asahina, Kazuya Yamaguchi, Taketo Yamaguchi, Takamichi Hattori, Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients Movement Disorders. ,vol. 20, pp. 680- 686 ,(2005) , 10.1002/MDS.20387
N. Ueno, A. Inui, A. Asakawa, F. Takao, Y. Komatsu, K. Kotani, R. Nishimura, M. Kasuga, Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus. Diabetologia. ,vol. 45, pp. 792- 797 ,(2002) , 10.1007/S00125-002-0835-4
Sakurai-Yamashita Yasuko, Takada Kohei, Takemura Keiko, Yamashita Kimihiro, Enjoji Akihito, Kanematsu Takashi, Taniyama Kohtaro, Ability of mosapride to bind to 5-HT4 receptor in the human stomach. Japanese Journal of Pharmacology. ,vol. 79, pp. 493- 496 ,(1999) , 10.1254/JJP.79.493